Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Chromatography. A|March 28, 2024
Development and validation of an LC-MS/MS method for quantifying NAD+ and related metabolites in mice sciatic nerves and its application to a nerve injury animal modelYongfen Ma, Li Deng, Zhenxia Du
Journal of Hepatocellular Carcinoma|April 17, 2026
Development and Validation of an Interpretable Machine Learning Model for Predicting Tumor Recurrence After Microwave Ablation in Small Hepatocellular CarcinomaYongfen Ma, Lei Zhao, Qing Zhao
Biochemistry and Biophysics Reports|August 27, 2025
Prognostic value and immune infiltration of novel markers TNRC6C/AMPD1 in pancreatic cancer microenvironmentYongting Lan, Wenyan Du, Yongfen Ma, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 2, 2023
High-throughput screening of LogD by using a sample pooling approach based on the traditional shake flask methodYongfen Ma, Xiaowei Chen, Huma Javeria, et al.
Heliyon|February 1, 2024
Accurate prediction of Kp,uu,brain based on experimental measurement of Kp,brain and computed physicochemical properties of candidate compounds in CNS drug discoveryYongfen Ma, Mengrong Jiang, Huma Javeria, et al.
Journal of Medicinal Chemistry|May 31, 2019
Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR InhibitorsWeijie Hou, Huan Sun, Yongfen Ma, et al.
Peerj|March 26, 2024
Comprehensive analysis of peroxisome proliferator-activated receptors to predict the drug resistance, immune microenvironment, and prognosis in stomach adenocarcinomasQing Jia, Baozhen Li, Xiulian Wang, et al.
Frontiers in Oncology|May 27, 2026
Esophageal intramural metastasis from adenocarcinoma of esophagogastric junction: a case report and literature reviewYongfen Ma, Chen-Wei Pu, Yao Zheng, et al.
Bioorganic & Medicinal Chemistry|March 11, 2018
Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitorsWeijie Hou, Yan Ren, Zhenhua Zhang, et al.
Clinical and Translational Science|July 1, 2024
A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participantsAna Liza Andresan Sun, John David Gillies, Yang Shen, et al.
Pageof 2